Obalon Therapeutics, Inc.
USD3.05
-0.19 (-5.86%)
CEO
Kelly Huang
IPO Date
2016-10-06
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Open
$3.25
Prev. Close
$3.24
Day Low
$2.95
Day High
$4.80
52W Low
$1.98
52W High
$32.31
Market Cap
$0.01B
Volume
26.47M
| -0.2 |
| 31 Dec 2020 | FY | 36.8% | -776.7% | -264.4% | -116.2% | 2.22 | 1.55 | -0.9 |
| 31 Dec 2019 | FY | 10.1% | -721.6% | -149.4% | -116.1% | 0.07 | 4.59 | -0.4 |
| 31 Dec 2018 | FY | 40.4% | -410.7% | -285.2% | -123.0% | 0.76 | 1.66 | -1.1 |
| 31 Dec 2017 | FY | 51.3% | -350.7% | -99.0% | -65.5% | 0.28 | 5.17 | -3.2 |
| 31 Dec 2016 | FY | 17.2% | -603.2% | -31.8% | -26.0% | 0.19 | 17.00 | -6.8 |
| 31 Dec 2015 | FY | 38.0% | -385.2% | 28.2% | -109.4% | -0.18 | 2.48 | -8.7 |
| 31 Dec 2014 | FY | 17.7% | -279.5% | 24.8% | -47.7% | -0.12 | 23.21 | -14.7 |
| 30 Sept 2025 | Q3 | 52.1% | -24822.5% | -339.8% | -122.0% | 0.02 | 1.94 | -0.1 |
| 30 Jun 2025 | Q2 | 48.2% | -211.8% | -45.1% | -29.1% | 0.02 | 2.77 | -0.3 |
| 31 Mar 2025 | Q1 | 61.2% | 132.4% | 119.8% | 22.7% | 0.11 | 1.53 | 0.4 |
| 31 Dec 2024 | Q4 | 62.9% | -20.6% | 645.9% | -34.1% | -3.82 | 0.92 | -0.2 |
| 30 Jun 2021 | Q2 | 61.0% | -110.6% | -0.0% | -0.0% | 0.01 | 1.08 | -1845.5 |
| 31 Mar 2021 | Q1 | 0.0% | 0.0% | -41.3% | -24.0% | 0.03 | 1.86 | -1.6 |
| 31 Dec 2020 | Q4 | 98.4% | -2172.1% | -28.4% | -12.5% | 1.16 | 1.55 | -2.2 |
| 30 Sept 2020 | Q3 | 6.8% | -3545.5% | -26.3% | -13.0% | 0.26 | 1.79 | -1.1 |